Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

Similar articles for PubMed (Select 1717820)

1.

Angiotensin converting enzyme inhibition in Dahl salt-sensitive rats.

Peeler TC, Baker KM, Esmurdoc CF, Chernin MI.

Mol Cell Biochem. 1991 May 29-Jun 12;104(1-2):45-50.

PMID:
1717820
2.

Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats.

Baker KM, Chernin MI, Wixson SK, Aceto JF.

Am J Physiol. 1990 Aug;259(2 Pt 2):H324-32.

PMID:
2143633
3.

Cardiac hypertrophy and cardiac renin-angiotensin system in Dahl rats on high salt intake.

Zhao X, White R, Van Huysse J, Leenen FH.

J Hypertens. 2000 Sep;18(9):1319-26.

PMID:
10994763
4.

Renin-angiotensin system and fibronectin gene expression in Dahl Iwai salt-sensitive and salt-resistant rats.

Tamura K, Chiba E, Yokoyama N, Sumida Y, Yabana M, Tamura N, Takasaki I, Takagi N, Ishii M, Horiuchi M, Umemura S.

J Hypertens. 1999 Jan;17(1):81-9.

PMID:
10100098
6.

Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat.

Lee MA, Böhm M, Kim S, Bachmann S, Bachmann J, Bader M, Ganten D.

Hypertension. 1995 Apr;25(4 Pt 1):570-80.

7.

Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes In vitro.

Malhotra R, Sadoshima J, Brosius FC 3rd, Izumo S.

Circ Res. 1999 Jul 23;85(2):137-46.

8.

Reduction of development of left ventricular hypertrophy in salt-loaded Dahl salt-sensitive rats by angiotensin II receptor inhibition.

de Simone G, Devereux RB, Camargo MJ, Wallerson DC, Sealey JE, Laragh JH.

Am J Hypertens. 1996 Mar;9(3):216-22.

PMID:
8695019
10.

Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats.

Nakano N, Moriguchi A, Morishita R, Kida I, Tomita N, Matsumoto K, Nakamura T, Higaki J, Ogihara T.

Hypertension. 1997 Dec;30(6):1448-54.

11.

High salt intake and the brain renin--angiotensin system in Dahl salt-sensitive rats.

Zhao X, White R, Huang BS, Van Huysse J, Leenen FH.

J Hypertens. 2001 Jan;19(1):89-98.

PMID:
11204309
12.
13.
14.

Normalisation of blood pressure in hypertensive TGR(mREN2)27 rats by amlodipine vs. enalapril: effects on cardiac hypertrophy and signal transduction pathways.

Witte K, Huser L, Knotter B, Heckmann M, Schiffer S, Lemmer B.

Naunyn Schmiedebergs Arch Pharmacol. 2001 Jan;363(1):101-9.

PMID:
11191827
15.
16.

Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis.

Luo JD, Zhang WW, Zhang GP, Guan JX, Chen X.

Clin Exp Pharmacol Physiol. 1999 Nov;26(11):903-8.

PMID:
10561812
19.

The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.

Keuneke C, Yacullo R, Metzger R, Hellmann T, Peters J, Ganten D.

Eur Heart J. 1990 May;11 Suppl D:11-6.

PMID:
2163328
20.

Correlation of left ventricular hypertrophy and its regression by lisinopril with salt-induced hypertension.

Snedden W, Fernandez PG, Fernandez D, Vasdev S, Rabin EZ.

Can J Cardiol. 1988 Jun-Aug;4(5):237-42.

PMID:
2842021
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk